Investigation of the Therapeutic Potential of Umbilical Cord Tissue Derived Mesenchymal Stem Cells
AJAS · 2018 Biomedical and Health Sciences (inferred)
Overview
Introduction: Inflammation and infection are important in the etiopathogenesis of pulmonary diseases. Umbilical cords are usually discarded postdelivery. Mesenchymal stem cells (hMSCs) derived from cord tissue were evaluated for their functional potential to treat infection and inflammation. Methods: hMSCs were cultured with or without lipopolysaccharide (LPS) or peptidoglycan (PEP). hMSC supernatants were analyzed for secreted cytokines using Luminex and for gene expression utilizing RT-PCR. hMSCs antimicrobial activity was measured by growth of Staphylococcus aureus (SA) and Pseudomonas aeruginosa (PA) and functionality by anti-inflammatory activity on epithelial cells. Results: hMSCs secreted cytokines IL-6 and IL-8. LPS and PEP enhanced cytokine secretion. hMSCs expressed genes for IL-6, IL-8, and MIP-3α. LPS increased expression of IL-6 and IL-8, while PEP decreased IL-6 and MIP-3α. hMSC supernatants were antimicrobial; they decreased SA CFUs from 150 to 68.5 and PA CFUs from 208.4 to 35.3 respectively after treatment for 2 hours (n=3, p≤0.05). Cord tissue derived hMSCs supernatants had anti-inflammatory activity, which was enhanced by LPS (5.64 vs 6.56 cycle difference). Conclusions: hMSCs secrete a variety of cytokines and display antimicrobial and anti-inflammatory activity. Donor variability was demonstrated. Donor related variability in the phenotypic properties might be important in the functionality of hMSCs.
Competition history
- AJAS 2018
Related projects
AJAS · 2017
Umbilical Cord Tissue Derived Mesenchymal Stem Cells: Therapy for Cystic Fibrosis
ISEF · 2015
Mesenchymal Stem Cells: Innovations in Infection and Inflammation Therapy
ISEF · 2022
Immunomodulatory Properties of Mesenchymal Stem Cells for Knee Osteoarthritis Prevention and Treatment
ISEF · 2023
In Vitro Characterization of Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) Supplemented With a Novel Xeno-Free, Human Blood-Derived Supplement
AJAS · 2020
Adult Stem Cells for Musculoskeletal Tissue Regeneration
ISEF · 2024
Investigating the Efficacy and Mechanisms of Mesenchymal Stem Cell Therapy in Celiac Disease: Year 2
ISEF · 2025
Tonsillar Mesenchymal Stem Cells Derived Cream for Muscular Dystrophy in Rats
ISEF · 2026
TGF-ß3–Driven Reversal of Mesenchymal Stem Cell Senescence for Improved Regenerative Medicine Applications
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: AAAS Annual Meeting (Confex) / American Junior Academy of Science